SubHero Banner
Text

October 2019

Core topics in this month’s edition include:

  • Farxiga (dapagliflozin) - new indication
  • Reyvow (lasmiditan) - new drug approval
  • Trikafta (elexacaftor/ tezacaftor/ivacaftor; ivacaftor) - new drug approval
  • Ranitidine recalls

Download PDF

Text